Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
KEOCYT logo — Crafting hope with innovative treatments for epilepsy and ca...

KEOCYT

Crafting hope with innovative treatments for epilepsy and cancer

Founded 2006 4 employees Pharmaceutical

General Information

Company Name KEOCYT
Founded Year 2006
Employees 4
Industries Pharmaceutical
Social

Get notified when KEOCYT moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About KEOCYT

KEOCYT is a pharmaceutical startup founded in 2006 that specializes in crafting innovative treatments for epilepsy and cancer. The company's slogan, "Crafting hope with innovative treatments for epilepsy and cancer," reflects its dedication to developing groundbreaking pharmaceutical products. KEOCYT's offerings include medications for managing epilepsy and treating cancer, with a product range featuring estramustin for prostate cancer, streptozocin for neuroendocrine tumors, and phenytoin and fosphenytoin for epilepsy management. As a Pharmaceutical company, KEOCYT holds promise in addressing critical medical needs, making it an attractive prospect for venture capital investment to further its research, development, and market penetration in the pharmaceutical industry.

Taxonomy: pharmaceuticals, drug development, epilepsy treatment, cancer treatment, oncology medications, neuroendocrine tumors, prostate cancer, pharmaceutical solutions, estramustin, streptozocin, phenytoin, fosphenytoin, medication management, innovative treatments

No funding data available for KEOCYT yet.

Get notified when KEOCYT raises funding

KEOCYT Alternatives & Competitors

KEOCYT vs
Kannoli Pharma
Kannoli Pharma Portugal

Kannoli Pharma (“Kannoli”), a brand owned by Alkannoli L.D.A., is a new ’disruptor‘ in EU Medical Ca...

3 employees
Manufacturing
KEOCYT vs
Sustainable Cell Therapeutics
Sustainable Cell Therapeutics

Pioneering cancer immunotherapy with a focus on patient rehabilitation and treatment of resilient an...

Seed
Biotechnology, Health Care
KEOCYT vs
SERO
SERO United States

Leading the Carolinas in Radiation Oncology through 40 years of innovation and care.

18 employees
Health Care

FAQ About KEOCYT

Crafting hope with innovative treatments for epilepsy and cancer
KEOCYT was founded in 2006.
KEOCYT operates in the following industries: Pharmaceutical.
KEOCYT has approximately 4 employees.
Top alternatives and competitors to KEOCYT include Kannoli Pharma, Sustainable Cell Therapeutics, SERO, Dana-Farber Cancer Institute, Cancer Council Australia. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
KEOCYT and Kannoli Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors KEOCYT and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy